MRP class of human ATP binding cassette (ABC) transporters: Historical background and new research directions

Xenobiotica

Volumn 38, Issue 7-8, 2008, Pages 833-862

  Toyoda, Y ^a   Hagiya, Y ^a   Adachi, T ^a   Hoshijima, K ^a   Kuo, M T ^b   Ishikawa, T ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ABC transporter; Glutathione; Multidrug resistance; Oxidative stress; Pharmacogenomics

Indexed keywords

ABC TRANSPORTER; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6; MULTIDRUG RESISTANCE PROTEIN 7; MULTIDRUG RESISTANCE PROTEIN 8; MULTIDRUG RESISTANCE PROTEIN 9; SULFONYLUREA RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

DRUG UPTAKE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; GLUTATHIONE METABOLISM; MOLECULAR CLONING; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; XENOBIOTIC METABOLISM;

BIOLOGICAL TRANSPORT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MULTIGENE FAMILY; MUTATION; OXIDATIVE STRESS; XENOBIOTICS;

EID: 48749108121     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250701883514     Document Type: Review

References (171)

1. Adachi T, Nakagawa H, Ivy C, Hagiya Y, Hoshijima K, Noguchi N, Kuo MT, Ishikawa T. 2007. Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. Journal of Experimental Therapeutics and Oncology 6:335-348.
2. Akerboom T, Inoue M, Sies H, Kinne R, Arias IM. 1984. Biliary transport of glutathione disulfide studied with isolated rat-liver canalicular-membrane vesicles. European Journal of Biochemistry 141:211-215.
3. Akerboom TP, Bilzer M, Sies H. 1982. Competition between transport of glutathione disulfide (GSSG) and glutathione S-conjugates from perfused rat liver into bile. FEBS Letters 140:73-76.
4. Akerboom TP, Sies H. 1989. Transport of glutathione, glutathione disulfide, and glutathione conjugates across the hepatocyte plasma membrane. Methods in Enzymology 173:523-534.
5. Annilo T, Dean M. 2004. Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. Genomics 84:34-46.
6. Augustine LM, Markelewicz RJ Jr, Boekelheide K, Cherrington NJ. 2005. Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metabolism and Disposition 33:182-189.
7. Bakos E, Evers R, Sinko E, Varadi A, Borst P, Sarkadi B. 2000. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Molecular Pharmacology 57:760-768.
8. Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K, De Haas M, Van Deemter L, Borst P, Varadi A, et al. 1998. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. Journal of Biological Chemistry 273:32167-32175.
9. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. 2002. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Research 62:6172-6177.
10. Bera TK, Iavarone C, Kumar V, Lee S, Lee B, Pastan I. 2002. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proceedings of the National Academy of Sciences, USA 99:6997-7002.
11. Bera TK, Lee S, Salvatore G, Lee B, Pastan I. 2001. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Molecular Medicine 7:509-516.
12. Bloom DA, Jaiswal AK. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:Quinone oxidoreductase-1 gene expression. Journal of Biological Chemistry 278:44675-44682.
13. Board P, Nishida T, Gatmaitan Z, Che M, Arias IM. 1992. Erythrocyte membrane transport of glutathione conjugates and oxidized glutathione in the Dubin-Johnson syndrome and in rats with hereditary hyperbilirubinemia. Hepatology 15:722-725.
14. Board PG. 1981. Transport of glutathione S-conjugate from human erythrocytes. FEBS Letters 124:163-165.
15. Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B. 2003. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. Journal of Biological Chemistry 278:23529-23537.
16. Borst P, Elferink RO. 2002. Mammalian ABC transporters in health and disease. Annual Review of Biochemistry 71:537-592.
17. Borst P, Evers R, Kool M, Wijnholds J. 2000. A family of drug transporters: The multidrug resistance-associated proteins. Journal of the National Cancer Institute 92:1295-11302.
18. Borst P, Zelcer N, Van de Wetering K, Poolman B. 2006. On the putative co-transport of drugs by multidrug resistance proteins. FEBS Letters 580:1085-1093.
19. Bortfeld M, Rius M, Konig J, Herold-Mende C, Nies AT, Keppler D. 2006. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience 137:1247-1257.
20. Brun ME, Ruault M, Ventura M, Roizes G, De Sario A. 2003. Juxtacentromeric region of human chromosome 21: A boundary between centromeric heterochromatin and euchromatic chromosome arms. Gene 312:41-50.
21. Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. 1996. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. Journal of Biological Chemistry 271:15091-15098.
22. Cadenas E, Sies H. 1985. Oxidative stress: Excited oxygen species and enzyme activity. Advances in Enzyme Regulation 23:217-237.
23. Chance B, Sies H, Boveris A. 1979. Hydroperoxide metabolism in mammalian organs. Physiological Reviews 59:527-605.
24. Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD. 2005. Transport of bile acids, sulfated steroids, estradiol 17-β-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Molecular Pharmacology 67:545-557.
25. Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E, Kruh GD. 2003. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Molecular Pharmacology 63:351-358.
26. Chen ZS, Lee K, Kruh GD. 2001. Transport of cyclic nucleotides and estradiol 17-β-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. Journal of Biological Chemistry 276:33747-33754.
27. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
28. Dean M, Rzhetsky A, Allikmets R. 2001. The human ATP-binding cassette (ABC) transporter superfamily. Genome Research 11:1156-1166.
29. Deeley RG, Cole SP. 2006. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Letters 580:1103-1111.
30. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences, USA 99:11908-11913.
31. Droge W. 2002. Free radicals in the physiological control of cell function. Physiological Reviews 82:47-95.
32. Elferink RP, Ottenhoff R, Liefting W, De Haan J, Jansen PL. 1989. Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. Journal of Clinical Investigation 84:476-483.
33. Elferink RP, Ottenhoff R, Liefting WG, Schoemaker B, Groen AK, Jansen P. 1990. ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. American Journal of Physiology. Gastrointestinal Liver Physiology 258:G699-G706.
34. Fahey RC, Sundquist AR. 1991. Evolution of glutathione metabolism. Advances in Enzymology and Related Areas of Molecular Biology 64:1-53.
35. Finkel T. 2003. Oxidant signals and oxidative stress. Current Opinion in Cell Biology 15:247-254.
36. Gilbert SF. 2000. Developmental biology, 6th Edn. Sunderland, MA: Sinauer Associates (available at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight= spermatogenesis&rid=dbio.section.4689) (accessed on 25 December 2007).
37. Giudice A, Montella M. 2006. Activation of the Nrf2-ARE signaling pathway: A promising strategy in cancer prevention. Bioessays 28:169-181.
38. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. 1992. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proceedings of the National Academy of Sciences, USA 89:3070-3074.
39. Gomi A, Shinoda S, Masuzawa T, Ishikawa T, Kuo MT. 1997. Transient induction of the MRP/GS-X pump and γ-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea in human glioma cells. Cancer Research 57:5292-5299.
40. Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD. 2003. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′- dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. Journal of Biological Chemistry 278:29509-29514.
41. Hayashi A, Suzuki H, Itoh K, Yamamoto M, Sugiyama Y. 2003. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochemical and Biophysical Research Communications 310:824-829.
42. Hayes JD, Flanagan JU, Jowsey IR. 2005. Glutathione transferases. Annual Review of Pharmacology and Toxicology 45:51-88.
43. Heijn M, Oude Elferink RP, Jansen PL. 1992. ATP-dependent multispecific organic anion transport system in rat erythrocyte membrane vesicles. American Journal of Physiology 262:C104-C110.
44. Higgins CF. 1992. ABC transporters: from microorganisms to man. Annual Review of Cell Biology 8:67-113.
45. Holtzclaw WD, Dinkova-Kostova AT, Talalay P. 2004. Protection against electrophile and oxidative stress by induction of phase 2 genes: The quest for the elusive sensor that responds to inducers. Advances in Enzyme Regulation 44:335-367.
46. Hopper E, Belinsky MG, Zeng H, Tosolini A, Testa JR, Kruh GD. 2001. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Letters 162:181-191.
47. Houwen R, Dijkstra M, Kuipers F, Smit EP, Havinga R, Vonk RJ. 1990. Two pathways for biliary copper excretion in the rat. The role of glutathione. Biochemical Pharmacology 39:1039-1044.
48. Huang HC, Nguyen T, Pickett CB. 2000. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proceedings of the National Academy of Sciences, USA 97:12475-12480.
49. Huber M, Guhlmann A, Jansen PL, Keppler D. 1987. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology 7:224-228.
50. Hwang C, Sinskey AJ, Lodish HF. 1992. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257:1496-1502.
51. Inoue M, Akerboom TP, Sies H, Kinne R, Thao T, Arias IM. 1984. Biliary transport of glutathione S-conjugate by rat liver canalicular membrane vesicles. Journal of Biological Chemistry 259:4998-5002.
52. Ishikawa T, Akerboom TP, Sies H. 1986a. Role of key defense systems in target organ toxicity. In: Cohen GM, editor. Target organ toxicity. Boca Raton, FL: CRC Press. pp 130-139.
53. Ishikawa T, Akimaru K, Nakanishi M, Tomokiyo K, Furuta K, Suzuki M, Noyori R. 1998. Anticancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump). Biochemical Journal 336(Pt 3):569-576.
54. Ishikawa T, Ali-Osman F. 1993. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. Journal of Biological Chemistry 268:20116-20125.
55. Ishikawa T, Bao JJ, Yamane Y, Akimaru K, Frindrich K, Wright CD, Kuo MT. 1996. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. Journal of Biological Chemistry 271:14981-14988.
56. Ishikawa T, Esterbauer H, Sies H. 1986b. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. Journal of Biological Chemistry 261:1576-1581.
57. Ishikawa T, Kobayashi K, Sogame Y, Hayashi K. 1989. Evidence for leukotriene C4 transport mediated by an ATP-dependent glutathione S-conjugate carrier in rat heart and liver plasma membranes. FEBS Letters 259:95-98.
58. Ishikawa T, Li ZS, Lu YP, Rea PA. 1997. The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression. Bioscience Reports 17:189-207.
59. Ishikawa T, Muller M, Klunemann C, Schaub T, Keppler D. 1990. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. Journal of Biological Chemistry 265:19279-19286.
60. Ishikawa T, Sies H. 1984. Cardiac transport of glutathione disulfide and S-conjugate. Studies with isolated perfused rat heart during hydroperoxide metabolism. Journal of Biological Chemistry 259:3838-3843.
61. Ishikawa T, Wright CD, Ishizuka H. 1994. GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. Journal of Biological Chemistry 269:29085-29093.
62. Ishikawa T, Zimmer M, Sies H. 1986c. Energy-linked cardiac transport system for glutathione disulfide. FEBS Letters 200:128-132.
63. Ishikawa T. 1989. ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles. Journal of Biological Chemistry 264:17343-17348.
64. Ishikawa T. 1992. The ATP-dependent glutathione S-conjugate export pump. Trends in Biochemical Sciences 17:463-468.
65. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development 13:76-86.
66. Jaiswal AK. 2004. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biology and Medicine 36:1199-1207.
67. Jansen PL, Groothuis GM, Peters WH, Meijer DF. 1987a. Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary-conjugated hyperbilirubinemia. Hepatology 7:71-76.
68. Jansen PL, Peters WH, Meijer DK. 1987b. Hepatobiliary excretion of organic anions in double-mutant rats with a combination of defective canalicular transport and uridine 5′-diphosphate-glucuronyltransferase deficiency. Gastroenterology 93:1094-1103.
69. Jedlitschky G, Burchell B, Keppler D. 2000. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. Journal of Biological Chemistry 275:30069-30074.
70. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. 1996. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Research 56:988-994.
71. Kartenbeck J, Leuschner U, Mayer R, Keppler D. 1996. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 23:1061-1066.
72. Karwatsky J, Leimanis M, Cai J, Gros P, Georges E. 2005. The leucotriene C4 binding sites in multidrug resistance protein 1 (ABCC1) include the first membrane multiple spanning domain. Biochemistry 44:340-351.
73. Kauffmann HM, Pfannschmidt S, Zoller H, Benz A, Vorderstemann B, Webster JI, Schrenk D. 2002. Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology 171:137-146.
74. -) rats with conjugated hyperbilirubinemia. Proceedings of the National Academy of Sciences, USA 87:3557-3561.
75. Klein I, Sarkadi B, Varadi A. 1999. An inventory of the human ABC proteins. Biochimica et Biophysica Acta 1461:237-262.
76. Klement JF, Matsuzaki Y, Jiang QJ, Terlizzi J, Choi HY, Fujimoto N, Li K, Pulkkinen L, Birk DE, Sundberg JP, Uitto J. 2005. Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Molecular and Cellular Biology 25:8299-8310.
77. Kobayashi K, Komatsu S, Nishi T, Hara H, Hayashi K. 1991. ATP-dependent transport for glucuronides in canalicular plasma membrane vesicles. Biochemical and Biophysical Research Communications 176:622-626.
78. Kobayashi K, Sogame Y, Hara H, Hayashi K. 1990. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. Journal of Biological Chemistry 265:7737-7741.
79. Kobayashi M, Yamamoto M. 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in Enzyme Regulation 46:113-140.
80. Kondo T, Dale GL, Beutler E. 1980. Glutathione transport by inside-out vesicles from human erythrocytes. Proceedings of the National Academy of Sciences, USA 77:6359-6362.
81. Kondo T, Murao M, Taniguchi N. 1982. Glutathione S-conjugate transport using inside-out vesicles from human erythrocytes. European Journal of Biochemistry 125:551-554.
82. Konig J, Rost D, Cui Y, Keppler D. 1999. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156-1163.
83. Kool M, De Haas M, Scheffer GL, Scheper RJ, Van Eijk MJ, Juijn JA, Baas F, Borst P. 1997. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Research 57:3537-3547.
84. Kool M, Van der Linden M, De Haas M, Baas F, Borst P. 1999. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Research 59:175-182.
85. Kruh GD, Belinsky MG. 2003. The MRP family of drug efflux pumps. Oncogene 22:7537-7552.
86. Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, Chen ZS. 2007. ABCC10, ABCC11, and ABCC12. Pflugers Archives: European Journal of Physiology 453:675-684.
87. Kuo MT, Bao J, Furuichi M, Yamane Y, Gomi A, Savaraj N, Masuzawa T, Ishikawa T. 1998. Frequent coexpression of MRP/GS-X pump and γ-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues. Biochemical Pharmacology 55:605-615.
88. Kuo MT, Bao JJ, Curley SA, Ikeguchi M, Johnston DA, Ishikawa T. 1996. Frequent coordinated overexpression of the MRP/GS-X pump and γ-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Research 56:3642-3644.
89. Kurz EU, Cole SP, Deeley RG. 2001. Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochemical and Biophysical Research Communications 285:981-990.
90. LaBelle EF, Singh SV, Srivastava SK, Awasthi YC. 1986. Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport. Biochemical Journal 238:443-449.
91. Lai L, Tan TM. 2002. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochemical Journal 361:497-503.
92. Lee FY, Siemann DW, Sutherland RM. 1989. Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer - a possible indicator of chemosensitivity. British Journal of Cancer 60:291-298.
93. Lee JM, Hanson JM, Chu WA, Johnson JA. 2001. Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. Journal of Biological Chemistry 276:20011-20016.
94. Lee WL, Tay A, Ong HT, Goh LM, Monaco AP, Szepetowski P. 1998. Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): confirmation of linkage to human chromosome 16p12-q12 in a Chinese family. Human Genetics 103:608-612.
95. Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, Mercer KE, Zhuang Y, Panetta JC, Johnston B. 2004. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Molecular and Cellular Biology 24:7612-7621.
96. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, Keppler D. 1994. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. Journal of Biological Chemistry 269:27807-27810.
97. Leslie EM, Bowers RJ, Deeley RG, Cole SP. 2003. Structural requirements for functional interaction of glutathione tripeptide analogs with the human multidrug resistance protein 1 (MRP1). Journal of Pharmacology and Experimental Therapeutics 304:643-653.
98. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, Cole SP. 2001. Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. Journal of Biological Chemistry 276:27846-27854.
99. Li L, Lee TK, Meier PJ, Ballatori N. 1998. Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. Journal of Biological Chemistry 273:16184-16191.
100. Li ZS, Zhao Y, Rea PA. 1995. Magnesium adenosine 5[prime]-triphosphate- energized transport of glutathione-S-conjugates by plant vacuolar membrane vesicles. Plant Physiology 107:1257-1268.
101. Lin-Lee YC, Tatebe S, Savaraj N, Ishikawa T, Tien Kuo M. 2001. Differential sensitivities of the MRP gene family and γ-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status. Biochemical Pharmacology 61:555-563.
102. Loe DW, Almquist KC, Cole SP, Deeley RG. 1996a. ATP-dependent 17 β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. Journal of Biological Chemistry 271:9683-9689.
103. Loe DW, Almquist KC, Deeley RG, Cole SP. 1996b. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. Journal of Biological Chemistry 271:9675-9682.
104. Loe DW, Deeley RG, Cole SP. 2000. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Journal of Pharmacology and Experimental Therapeutics 293:530-538.
105. Maher JM, Slitt AL, Cherrington NJ, Cheng X, Klaassen CD. 2005. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metabolism and Disposition 33:947-955.
106. Manciu L, Chang XB, Buyse F, Hou YX, Gustot A, Riordan JR, Ruysschaert JM. 2003. Intermediate structural states involved in MRP1-mediated drug transport. Role of glutathione. Journal of Biological Chemistry 278:3347-3356.
107. Martinoia E, Grill E, Tommasini R, Kreuz K, Amrhein N. 1993. ATP-dependent glutathione S-conjugate 'export' pump in the vacuolar membrane of plants. Nature 364:247-249.
108. Meister A, Anderson ME. 1983. Glutathione. Annual Review of Biochemistry 52:711-760.
109. Moran JA, Dahl EL, Mulcahy RT. 2002. Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators. Biochemical Journal 361:371-377.
110. Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends in Molecular Medicine 10:549-557.
111. Muller M, Meijer C, Zaman GJ, Borst P, Scheper RJ, Mulder NH, De Vries EG, Jansen PL. 1994. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proceedings of the National Academy of Sciences, USA 91:13033-13037.
112. Muredda M, Nunoya K, Burtch-Wright RA, Kurz EU, Cole SP, Deeley RG. 2003. Cloning and characterization of the murine and rat mrp1 promoter regions. Molecular Pharmacology 64:1259-1269.
113. Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, Kaminuma T, Ishikawa T. 2006. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metabolism and Pharmacokinetics 21:437-457.
114. Nguyen T, Huang HC, Pickett CB. 2000. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. Journal of Biological Chemistry 275:15466-15473.
115. Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB. 2005. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. Journal of Biological Chemistry 280:32485-32492.
116. Nguyen T, Yang CS, Pickett CB. 2004. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radical Biology and Medicine 37:433-441.
117. Nies AT, Jedlitschky G, Konig J, Herold-Mende C, Steiner HH, Schmitt HP, Keppler D. 2004. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129:349-360.
118. Oguri T, Bessho Y, Achiwa H, Ozasa H, Maeno K, Maeda H, Sato S, Ueda R. 2007. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Molecular Cancer Therapeutics 6:122-127.
119. Ono N, Van der Heijden I, Scheffer GL, Van de Wetering K, Van Deemter E, De Haas M, Boerke A, Gadella BM, De Rooij DG, Neefjes JJ, et al. 2007. Multidrug resistance-associated protein 9 (ABCC12) is present in mouse and boar sperm. Biochemical Journal 406:31-40.
120. Ozawa N, Guengerich FP. 1983. Evidence for formation of an S-[2-(N7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA. Proceedings of the National Academy of Sciences, USA 80:5266-5270.
121. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P, Oude Elferink RP. 1996. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271:1126-1128.
122. Perez RP, Hamilton TC, Ozols RF. 1990. Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems. Pharmacology and Therapeutics 48:19-27.
123. Qian YM, Song WC, Cui H, Cole SP, Deeley RG. 2001. Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. Journal of Biological Chemistry 276:6404-6411.
124. Rahman I, Smith CA, Lawson MF, Harrison DJ, MacNee W. 1996. Induction of γ-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Letters 396:21-25.
125. Rea PA, Sanches-fernandez R, Chen S, Peng M, Klein M, Geisler M, Martinoia E. 2003. The plant ABC transporter superfamily: The functions of a few and identities of many. In: Holland IB, Cole SP, Kuchler K, Higgins CF, editors. ABC proteins from bacteria to man. Amsterdam: Academic Press. pp 335-355.
126. Reed DJ. 1990. Glutathione: Toxicological implications. Annual Review of Pharmacology and Toxicology 30:603-631.
127. Ren XQ, Furukawa T, Nakajima Y, Takahashi H, Aoki S, Sumizawa T, Haraguchi M, Kobayashi M, Chijiiwa K, Akiyama S. 2005. GSH inhibits trypsinization of the C-terminal half of human MRP1. Journal of Biological Chemistry 280:6231-6237.
128. Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D. 2006. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. American Journal of Physiology. Gastrointestinal Liver Physiology 290:G640-G649.
129. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. 2003. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38:374-384.
130. Rushmore TH, Morton MR, Pickett CB. 1991. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. Journal of Biological Chemistry 266:11632-11639.
131. Sakurai A, Onishi Y, Hirano H, Seigneuret M, Obanayama K, Kim G, Liew EL, Sakaeda T, Yoshiura K, Niikawa N, et al. 2007. Quantitative structure - activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporter ABCB1 (P-glycoprotein/MDR1). Biochemistry 46:7678-7693.
132. Sekhar KR, Soltaninassab SR, Borrelli MJ, Xu ZQ, Meredith MJ, Domann FE, Freeman ML. 2000. Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for γ-glutamylcysteine synthetase. Biochemical and Biophysical Research Communications 270:311-317.
133. Shimizu H, Taniguchi H, Hippo Y, Hayashizaki Y, Aburatani H, Ishikawa T. 2003. Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. Gene 310:17-28.
134. Sies H, editor. 1985. Oxidative stress. Orlando, FL: Academic Press.
135. Sies H. 1988. In: Sies H, Ketterer B, editors. Glutathione conjugation: mechanisms and biological significance. London: Academic Press. pp 176-192.
136. Smith CV, Jones DP, Guenthner TM, Lash LH, Lauterburg BH. 1996. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicology and Applied Pharmacology 140:1-12.
137. Srivastava SK, Beutler E. 1969. The transport of oxidized glutathione from human erythrocytes. Journal of Biological Chemistry 244:9-16.
138. Suzuki M, Mori M, Niwa T, Hirata R, Furuta K, Ishikawa T, Noyori R. 1997. Chemical implications for antitumor and antiviral prostaglandins - reaction of delta(7)-prostaglandin A(1) and prostaglandin A(1) methyl-esters with thiols. Journal of the American Chemical Society 119:2376-2385.
139. Takayanagi S, Kataoka T, Ohara O, Oishi M, Kuo MT, Ishikawa T. 2004. Human ATP-binding cassette transporter ABCC10: Expression profile and p53-dependent upregulation. Journal of Experimental Therapeutics and Oncology 4:239-246.
140. Takikawa H, Sano N, Narita T, Uchida Y, Yamanaka M, Horie T, Mikami T, Tagaya O. 1991. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 14:352-360.
141. Talalay P, Dinkova-Kostova AT, Holtzclaw WD. 2003. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Advances in Enzyme Regulation 43:121-134.
142. Tammur J, Prades C, Arnould I, Rzhetsky A, Hutchinson A, Adachi M, Schuetz JD, Swoboda KJ, Ptacek LJ, Rosier M, et al. 2001. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 273:89-96.
143. Tanaka T, Uchiumi T, Hinoshita E, Inokuchi A, Toh S, Wada M, Takano H, Kohno K, Kuwano M. 1999. The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology 30:1507-1512.
144. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, Kuwano M. 1996. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Research 56:4124-4129.
145. Tatebe S, Sinicrope FA, Kuo MT. 2002a. Induction of multidrug resistance proteins MRP1, & MRP3 and γ-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochemical and Biophysical Research Communications 290:1427-1433.
146. Tatebe S, Unate H, Sinicrope FA, Sakatani T, Sugamura K, Makino M, Ito H, Savaraj N, Kaibara N, Kuo MT. 2002b. Expression of heavy subunit of γ-glutamylcysteine synthetase (γ-GCSh) in human colorectal carcinoma. International Journal of Cancer 97:21-27.
147. Tomita H, Nagamitsu S, Wakui K, Fukushima Y, Yamada K, Sadamatsu M, Masui A, Konishi T, Matsuishi T, Aihara M, et al. 1999. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. American Journal of Human Genetics 65:1688-1697.
148. Tomonari A, Nishio K, Kurokawa H, Arioka H, Ishida T, Fukumoto H, Fukuoka K, Nomoto T, Iwamoto Y, Heike Y, et al. 1997. Identification of cis-acting DNA elements of the human γ-glutamylcysteine synthetase heavy subunit gene. Biochemical and Biophysical Research Communications 232:522-527.
149. Townsend DM, Tew KD. 2003. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369-7375.
150. Urata Y, Honma S, Goto S, Todoroki S, Iida T, Cho S, Honma K, Kondo T. 1999. Melatonin induces γ-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radical Biology and Medicine 27:838-847.
151. Versantvoort CH, Broxterman HJ, Bagrij T, Scheper RJ, Twentyman PR. 1995. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. British Journal of Cancer 72:82-89.
152. Vollrath V, Wielandt AM, Iruretagoyena M, Chianale J. 2006. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochemical Journal 395:599-609.
153. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P. 2004. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proceedings of the National Academy of Sciences, USA 101:2040-2045.
154. Wielinga PR, Van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P. 2003. Characterization of the MRP4-and MRP5-mediated transport of cyclic nucleotides from intact cells. Journal of Biological Chemistry 278:17664-17671.
155. Wijnholds J, Evers R, Van Leusden MR, Molecular CA, Zaman GJ, Mayer U, Beijnen JH, Van der Valk M, Krimpenfort P, Borst P. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Medicine 3:1275-1279.
156. Wijnholds J, Molecular CA, Van Deemter L, De Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, et al., 2000. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proceedings of the National Academy of Sciences, USA 97:7476-7481.
157. Williams RT. 1978. Species variations in the pathways of drug metabolism. Environmental Health Perspectives 22:133-138.
158. Winyard PG, Moody CJ, Jacob C. 2005. Oxidative activation of antioxidant defence. Trends in Biochemical Sciences 30:453-461.
159. Yabuuchi H, Shimizu H, Takayanagi S, Ishikawa T. 2001. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochemical and Biophysical Research Communications 288:933-939.
160. Yabuuchi H, Takayanagi S, Yoshinaga K, Taniguchi N, Aburatani H, Ishikawa T. 2002. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochemistry and Biophysical Research Communications 299:410-417.
161. Yamane Y, Furuichi M, Song R, Van NT, Mulcahy RT, Ishikawa T, Kuo MT. 1998. Expression of multidrug resistance protein/GS-X pump and γ-glutamylcysteine synthetase genes is regulated by oxidative stress. Journal of Biological Chemistry 273:31075-31085.
162. Yang Y, Chen Q, Zhang JT. 2002. Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistance-associated protein 1. Journal of Biological Chemistry 277:44268-44277.
163. Yoshiura K, Kinoshita A, Ishida T, Ninokata A, Ishikawa T, Kaname T, Bannai M, Tokunaga K, Sonoda S, Komaki R, et al. 2006. A SNP in the ABCC11 gene is the determinant of human earwax type. Nature Genetics 38:324-330.
164. Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, Kong AN. 2000. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. Journal of Biological Chemistry 275:39907-39913.
165. Zaman GJ, Lankelma J, Van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P. 1995. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proceedings of the National Academy of Sciences, USA 92:7690-7694.
166. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscheer P, Schellens JH, Schinkel AH, Borst P. 2003. Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). Journal of Biological Chemistry 278:23538-23544.
167. Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P. 2001. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). Journal of Biological Chemistry 276:46400-46407.
168. Zelcer N, Van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR, Tephly T, Dahan A, Beijnen JH, Borst P. 2005. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proceedings of the National Academy of Sciences, USA 102:7274-7279.
169. Zhu Q, Center MS. 1994. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Research 54:4488-4492.
170. Zhu Q, Center MS. 1996. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. DNA and Cell Biology 15:105-111.
171. Zipper LM, Mulcahy RT. 2000. Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochemical and Biophysical Research Communications 278:484-492.